Watson David O.

Insider CIK 1657719 · APLS General Counsel

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	82,500	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	38,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	45,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	50,974	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	14,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	34,533	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	37,708	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	28,508	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	144,517	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	10,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	50,136	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	6,001	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	11,874	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	55,986	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	32,072	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	55,986	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	55,986	—	$0	55,986	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	27,993	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	27,993	—	$0	27,993	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	7,363	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	28,508	—	$0	28,508	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	41,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	41,250	—	$0	41,250	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-01-28	2026-01-30	55,986	—	$0	144,517	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-22	2026-01-23	7,832	$21.77	$170.5K	88,531	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-20	2026-01-21	2,475	$19.79	$49.0K	96,363	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-13	2026-01-15	5,780	$22.19	$128.3K	98,838	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2026-01-07	2026-01-09	888	—	$0	14,000	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2026-01-07	2026-01-09	888	$14.95	$13.3K	104,618	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-12-16	2025-12-18	5,000	$24.49	$122.4K	103,730	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-11-17	2025-11-18	5,000	$20.06	$100.3K	108,730	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-10-16	2025-10-17	5,000	$25.22	$126.1K	113,730	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-09-16	2025-09-18	5,000	$24.34	$121.7K	118,730	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-09-10	2025-09-12	20,000	$26.17	$523.4K	50,136	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-08-18	2025-08-19	5,000	$27.80	$139.0K	123,730	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-07-16	2025-07-18	5,000	$19.55	$97.8K	128,730	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-06-16	2025-06-18	5,000	$18.77	$93.8K	133,730	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2025-06-09	2025-06-11	82,500	$19.39	$1.60M	82,500	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-03-05	2025-03-06	5,569	$25.10	$139.8K	138,730	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2025-03-04	2025-03-06	6,667	—	$0	10,000	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2025-03-04	2025-03-06	6,667	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-29	2025-01-30	695	$29.52	$20.5K	144,299	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-22	2025-01-23	3,323	$30.43	$101.1K	144,994	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2025-01-21	2025-01-21	42,762	—	$0	148,317	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-17	2025-01-21	2,201	$29.96	$65.9K	105,555	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-13	2025-01-14	4,965	$28.70	$142.5K	107,756	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-12-11	2024-12-13	5,000	$34.24	$171.2K	112,721	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2024-09-27	2024-09-30	10,569	—	$0	117,721	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2024-09-27	2024-09-30	10,569	—	$0	70,136	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2024-03-06	2024-03-08	3,762	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2024-03-06	2024-03-08	3,762	$13.85	$52.1K	107,152	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-02-12	2024-02-13	781	$67.77	$52.9K	103,390	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-29	2024-01-31	906	$64.14	$58.1K	104,171	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-22	2024-01-23	4,184	$65.00	$272.0K	105,077	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2024-01-16	2024-01-17	34,533	$66.30	$2.29M	34,533	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2024-01-16	2024-01-17	23,748	—	$0	113,501	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-16	2024-01-17	4,240	$66.81	$283.3K	109,261	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-12-19	2023-12-20	7,905	—	$0	3,762	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-12-19	2023-12-20	1,605	$57.00	$91.5K	92,053	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-12-19	2023-12-20	7,905	$13.85	$109.5K	93,658	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-12-19	2023-12-20	2,300	$57.38	$132.0K	89,753	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-07-03	2023-07-06	8,510	$89.98	$765.7K	85,753	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-06-28	2023-06-29	12,750	—	$0	80,705	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-06-28	2023-06-29	12,750	—	$0	94,263	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-21	2023-04-24	67,955	—	$0	107,013	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-21	2023-04-24	67,955	—	$0	67,955	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-02-21	2023-02-22	14,023	—	$0	14,023	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-02-21	2023-02-22	825	$58.50	$48.3K	174,968	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-02-21	2023-02-22	9,886	—	$0	175,793	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-02-10	2023-02-14	532	$51.21	$27.2K	165,907	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-01-27	2023-01-30	551	$52.77	$29.1K	166,439	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-01-20	2023-01-24	2,034	$52.05	$105.9K	166,990	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-01-12	2023-01-17	37,708	$52.66	$1.99M	37,708	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-01-12	2023-01-17	24,003	—	$0	139,572	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-01-12	2023-01-17	29,452	—	$0	169,024	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-06-22	2022-06-23	10,000	$44.51	$445.1K	115,569	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-04-25	2022-04-27	5,000	$50.00	$250.0K	125,569	SEC↗
APLS Apellis Pharmaceuticals, I	J Other deriv	2022-04-21	2022-04-27	11,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	J Other	2022-04-21	2022-04-27	1,875	—	$0	130,569	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2022-02-10	2022-02-14	491	$47.12	$23.1K	132,444	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2022-01-28	2022-02-01	650	$38.59	$25.1K	132,935	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2022-01-21	2022-01-25	36,951	—	$0	36,951	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2022-01-21	2022-01-25	26,051	—	$0	133,585	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-12-27	2021-12-28	1,200	$48.50	$58.2K	107,534	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-12-22	2021-12-23	5,174	—	$0	16,493	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-12-22	2021-12-23	4,826	—	$0	11,667	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-12-22	2021-12-23	4,715	—	$0	20,285	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-12-22	2021-12-23	5,397	—	$0	14,888	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-12-22	2021-12-23	4,715	$14.95	$70.5K	108,734	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-12-22	2021-12-23	5,097	$47.86	$243.9K	109,034	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-12-22	2021-12-23	5,397	$14.95	$80.7K	114,131	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-12-22	2021-12-23	300	$48.58	$14.6K	108,734	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-12-22	2021-12-23	5,174	$47.72	$246.9K	104,019	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-12-22	2021-12-23	4,826	$13.85	$66.8K	109,193	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-12-22	2021-12-23	5,174	$13.85	$71.7K	104,367	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-09-10	2021-09-13	954	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-09-10	2021-09-13	954	$4.31	$4.1K	99,193	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-06-21	2021-06-22	489	—	$0	954	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-06-21	2021-06-22	489	$4.31	$2.1K	98,239	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-05-28	2021-06-01	489	—	$0	1,443	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-05-28	2021-06-01	489	$4.31	$2.1K	97,750	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-04-22	2021-04-23	489	—	$0	1,932	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-04-22	2021-04-23	489	$4.31	$2.1K	97,261	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-03-22	2021-03-23	978	—	$0	2,421	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-03-22	2021-03-23	978	$4.31	$4.2K	96,772	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2021-02-10	2021-02-11	468	$47.72	$22.3K	95,794	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2021-01-28	2021-02-01	45,000	—	$0	45,000	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2021-01-28	2021-02-01	11,250	—	$0	11,250	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2021-01-28	2021-02-01	7,500	—	$0	94,387	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2021-01-28	2021-02-01	1,875	—	$0	96,262	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-01-27	2021-01-29	20,042	—	$0	3,399	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-01-27	2021-01-29	23,441	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-01-27	2021-01-29	20,042	$4.31	$86.4K	86,887	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-01-27	2021-01-29	23,441	$3.76	$88.1K	66,845	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-12-14	2020-12-15	8,398	—	$0	21,667	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-12-14	2020-12-15	8,398	$13.85	$116.3K	51,802	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-14	2020-12-15	900	$55.00	$49.5K	43,604	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-14	2020-12-15	900	$53.86	$48.5K	44,504	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-14	2020-12-15	1,163	$52.73	$61.3K	45,404	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-14	2020-12-15	2,526	$51.32	$129.6K	46,567	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-14	2020-12-15	2,709	$50.61	$137.1K	49,093	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-14	2020-12-15	200	$55.91	$11.2K	43,404	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-12-11	2020-12-15	9,935	—	$0	30,065	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-11	2020-12-15	9,935	$50.00	$496.8K	43,404	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-12-11	2020-12-15	9,935	$13.85	$137.6K	53,339	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-02-10	2020-02-12	7,505	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2020-02-10	2020-02-12	38,250	—	$0	38,250	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2020-02-10	2020-02-12	6,375	—	$0	40,417	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-02-10	2020-02-12	7,505	$2.67	$20.0K	42,922	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-02-10	2020-02-12	5,000	$44.50	$222.5K	35,417	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-01-27	2020-01-28	15,000	—	$0	7,505	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-01-27	2020-01-28	15,000	$2.67	$40.0K	34,042	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-01-27	2020-01-28	3,000	$40.47	$121.4K	19,042	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2019-08-07	2019-08-09	5,000	—	$0	22,505	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2019-08-07	2019-08-09	5,000	$2.67	$13.3K	22,042	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2019-02-08	2019-02-12	40,000	—	$0	40,000	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2018-09-14	2018-09-17	32,818	—	$0	27,505	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2018-09-14	2018-09-17	32,818	$2.67	$87.6K	32,818	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2018-09-14	2018-09-17	15,776	$18.78	$296.3K	17,042	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2018-05-29	2018-05-30	624	—	$0	60,323	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2018-05-29	2018-05-30	624	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2018-05-29	2018-05-30	624	$2.67	$1.7K	624	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2018-02-16	2018-02-21	25,000	—	$0	25,000	SEC↗